Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04612530
Title PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amsterdam UMC, location VUmc
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD

Facility Status City State Zip Country Details
Amsterdam University Medical Centre (location VUmc) RECRUITING Amsterdam North-Holland 1081HV Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field